Exposure, Relaxation, and Rescripting Therapy for Trauma Nightmares
(ERRT Trial)
Trial Summary
The trial information does not specify whether you need to stop taking your current medications. It is best to discuss this with the trial coordinators or your doctor.
Research shows that ERRT, which includes techniques like imagery rehearsal and exposure, can reduce the frequency and severity of nightmares, improve sleep quality, and decrease symptoms of posttraumatic stress and depression. Studies have found that similar therapies, such as imagery rescripting and imaginal exposure, are effective in reducing nightmare symptoms and distress.
12345Research on Exposure, Relaxation, and Rescripting Therapy (ERRT) for trauma-related nightmares suggests it is generally safe, as studies report improvements in nightmare frequency and psychological distress without mentioning significant adverse effects.
12345ERRT is unique because it combines exposure to nightmare content, relaxation techniques, and rescripting (changing the storyline) of the nightmare, with an enhanced focus on exposure and incorporating trauma themes, which is different from other therapies that may not emphasize all these components together.
12345Eligibility Criteria
This trial is for adults who have experienced a traumatic event and suffer from frequent trauma-related nightmares, at least once weekly over the past month. Participants must be able to read and speak English. It's not suitable for individuals under 18, those with active suicidal thoughts, unmedicated bipolar disorder, recent substance abuse issues, psychosis, recent self-harm behaviors or intellectual disabilities.Inclusion Criteria
Exclusion Criteria
Trial Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive 5 to 6 weekly sessions of Exposure, Relaxation, and Rescripting Therapy (ERRT) for chronic post-trauma nightmares
Follow-up
Participants are monitored for changes in nightmare frequency and other symptoms after treatment
Participant Groups
Exposure, Relaxation, and Rescripting Therapy is already approved in United States, European Union for the following indications:
- Trauma-related nightmares
- Sleep disturbances
- PTSD symptoms
- Depression symptoms
- Trauma-related nightmares
- Sleep disturbances
- PTSD symptoms
- Depression symptoms